Zhou J. & Wang T., Molecular Modelling in Drug Design. China Science Press: Beijing, 2001.
Link: http://dx.doi.org/10.1007/s11426-013-4911-z
2. Wang T. & Duan Y. HIV co-receptor CCR5: structure and interactions with inhibitors. Infectious Disorders-Drug Targets- special in silico issue, 2009, 9, 279-288. Abstract: The CC-chemokine receptor 5 (CCR5), a membrane protein belonging to the G-protein coupled receptor super-family, has been identified as an essential co-receptor for HIV entry into the cells, and small molecules that inhibit HIV entry by targeting CCR5 have been in fast development as antiviral agents. This review focuses on computational studies of predicting the CCR5 structure and its interactions with known small molecule inhibitors and discusses how the recently solved GPCR structures would provide new insights into the modeling of CCR5-inhibitior binding. In addition, this review pays a particular attention to the design of the inhibitors that specifically interrupt the viral entry co-receptor activity of CCR5 while preserving its normal chemokine receptor function to minimize side effects and toxicity.
Link: http://www.ncbi.nlm.nih.gov/pubmed/19519482
3. Wang T. Flexible docking by molecular dynamics simulation. Computers and Applied Chemistry, 2007, 24, 91-93. Abstract: Computational molecular docking has obtained increasingly success in the past two decades. However molecular conformational flexibility remains a major challenge. This review will outline the recent progress in flexible docking and focus on the molecular dynamics simulation techniques.
Link: http://d.wanfangdata.com.cn/Periodical_jsjyyyhx200701018.aspx
4. Schleinkofer K., Wang T., & Wade R., Molecular Docking. In: Ganten, D & Ruckpaul, K (eds). Encyclopedic Reference of Genomics and Proteomics in Molecular Medicine, Springer, Berlin Heidelberg New York, 2006, pp 1149-1153
5. Wade R., Henrich S., & Wang T. Using 3D protein structures to derive 3D-QSARs. Drug Discovery Today: Technologies, 2004, 1, 241-246. Abstract: The three-dimensional structures of proteins are being solved apace, yet this information is often underused in quantitative structure-activity relationship (QSAR) studies. Here, we describe and compare methods for exploiting protein structures to derive 3D-QSARs. These methods can facilitate molecular design and lead optimization and should increasingly become a standard component of the drug designer's repertoire.
Link: http://dx.doi.org/10.1016/j.ddtec.2004.11.018
6. Wang T. & Zhou J. Three-dimensional structure searching in drug design. Progress in Chemistry, 1998, 10, 442-450. Abstract: Three-dimentional (3D) searching in a database of molecules based on their 3D characteristics has become a fast and effective approach to discover leading compounds. This review describes its principle, development and application in drug design.